Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphoseek for Sentinel Lymph Node Detection in Cervical Cancer
NCT02509585Phase 2Terminated
- Sponsor
- Cardinal Health
- Start
- Jan 2016
- Primary completion
- Jul 2017
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of technetium tc 99m tilmanocept in Cervical Cancer (CC), sponsored by Cardinal Health. Started Jan 2016; status: terminated.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02509585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509585.